IMPORTANT INFORMATION ABOUT YOUR REPEAT PRESCRIPTION

You have been identified as being prescribed NovoRapid Flexpen 100units/ml solution for injection 3ml pre-filled pen to control your diabetes. Other companies are now able to produce versions of NovoRapid which are referred to as biosimilars. The biosimilars are essentially the same as NovoRapid but they are more cost-effective, this helps support the NHS in meeting its affordability challenge while maintaining excellent diabetes care. 

Trurapi currently represents the best value for money for the NHS compared to NovoRapid. The money saved by prescribing Trurapi can then be used to contribute toward further NHS services. 

To help us achieve that goal, we are switching all patients who are prescribed NovoRapid Flexpen 100units/ml solution for injection 3ml pre-filled pen to Trurapi 100units/ml solution for injection 3ml pre-filled Solostar pen, which is a biosimilar-insulin and is made by a large pharmaceutical company (Sanofi), who have produced other insulins for many years. 

There will be instructions provided to you in the Trurapi patient starter pack demonstrating how to use the new Trurapi 100units/ml solution for injection 3ml pre-filled Solostar pen. Please use up all supplies of your current NovoRapid insulin before starting to use your new Trurapi 100units/ml solution for injection 3ml pre-filled Solostar pen.  

When you next request your medication, you will notice the following change. The number of units will be exactly the same and the only difference is the name of the pen device - Solostar instead of Flexpen, however you will use it in exactly the same way.

Old Prescription 

New Prescription 

NovoRapid Flexpen 100units/ml solution for injection 3ml pre-filled pen 

Trurapi 100units/ml solution for injection 3ml pre-filled Solostar pen

 

Please book an appointment for a blood test (HbA1c) three months after starting the new medication to assess continued effectiveness of your diabetes treatment.

We do not anticipate that you will experience any problems with your new medicine.  Please continue to monitor your blood glucose at home in the usual way.  

If you have any queries please speak to your GP, nurse, practice pharmacist or diabetes team. As with all medicines please read the patient information leaflet for your new medicine.